WO2000011205A1 - Optical oxidative enzyme-based sensors - Google Patents

Optical oxidative enzyme-based sensors Download PDF

Info

Publication number
WO2000011205A1
WO2000011205A1 PCT/IB1999/001451 IB9901451W WO0011205A1 WO 2000011205 A1 WO2000011205 A1 WO 2000011205A1 IB 9901451 W IB9901451 W IB 9901451W WO 0011205 A1 WO0011205 A1 WO 0011205A1
Authority
WO
WIPO (PCT)
Prior art keywords
oxygen
oxidative enzyme
phenanthroline
layer
sensors
Prior art date
Application number
PCT/IB1999/001451
Other languages
French (fr)
Inventor
Thomas C. Collins
Christiane Munkholm
Rudolf E. Slovacek
Original Assignee
Bayer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corporation filed Critical Bayer Corporation
Priority to AU51883/99A priority Critical patent/AU5188399A/en
Priority to EP99936915A priority patent/EP1112374A1/en
Priority to JP2000566457A priority patent/JP2002523733A/en
Priority to CA002340983A priority patent/CA2340983A1/en
Publication of WO2000011205A1 publication Critical patent/WO2000011205A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/904Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/906Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/978Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/98Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/978Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/986Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)

Definitions

  • This invention generally relates to instrumentation for sensing various blood analytes, and more particularly towards optical sensors for detecting blood components which are substrates for oxidative enzymes.
  • Patent Nos. 4,680,268, 5,352,348, and 5,298,144 are disadvantageous for use in disposable applications, because they were designed to function in a multiuse format with an elaborate instrument system, and they employ expensive materials and methods of manufacture as well as requiring wet up and calibration before use.
  • Disposable or "one-shot” sensors have been disclosed also, such as the colorimetric sensor set forth in U. S. Patent No. 5,208.147.
  • Disposable dry reagent strips e.g., U.S. Patent Nos. 3,992,158, 4,689.309, and 5,520.883. were developed specifically for single use applications. In operation, the sample hydrates the test strip and reagents are consumed in the development of a colorimetric change based on peroxide chemistries. They can be stored dry, are ready to use on demand, and find use in "wet" blood or serum chemistry, where the strips become saturated during use.
  • An advantage of these sensors is that it is possible to bring the sensor into intimate contact with a blood sample while transmitting excitation light through the transparent substrate from the "back" side of the sensor, to enable subsequent detection of the luminescent radiation emitted from the luminescent dye from the same side of the sensor.
  • Such coatings or membranes are quite thin, typically l-5 ⁇ m for pH and oxygen sensors, and show an extremely rapid response.
  • red blood cells will be in contact with the sensor. Since the principal of operation of optical glucose sensors is based on oxidization of available glucose in the blood sample by immobilized glucose oxidase in the sensor (i.e.. the detection of oxygen is directly correlatable to the glucose concentration), the depletion of oxygen proximate to the membrane will be high. As such, red blood cells (RBCs) in contact with the sensor will sense the low oxygen concentration at the membrane surface and respond by releasing bound oxygen, thus acting as an oxygen buffer and skewing the results obtained.
  • the presently-disclosed invention relates to enzyme-based optical sensors for detecting blood components which are substrates for oxidative enzymes, the sensors advantageously employing a multiple-layer structure featuring a thin, rapidly responding, optical, oxygen sensing layer.
  • the sensor comprises, in order, a) a rapidly hydrating gas-permeable cover, or spacer, layer; b) an enzymatic layer containing an oxidative enzyme also in a water and oxygen-permeable matrix; c) an oxygen sensing layer containing luminescent dye in a light-transmissive. oxygen- permeable matrix; and, preferably, d) a light-transmissive substrate.
  • the oxygen sensing layer further comprises an effective amount of a particulate filler material to reduce or eliminate sample light scattering effects.
  • the inventive sensors may be used to detect glucose and other enzyme-oxidizable analytes such as lactate or cholesterol.
  • the sensor additionally comprises, an enzyme "cascade" system instead of a single oxidative enzyme in the enzymatic layer containing a water and oxygen-permeable matrix. These sensors may be employed to detect analytes such as creatinine. which may not be enzymatically oxidized by a single enzyme but require several enzymatic steps to generate an oxidizable analyte derivative.
  • the sensors of this disclosure may be made easily using standard coating techniques known in the art.
  • the sensors are adaptable for reuse, but available materials and methods allow the sensors to be disposable as well, permitting their wide use in medical and analytical applications.
  • FIG. 1 is a cross-sectional view of a sensor in accordance with one embodiment of the presently disclosed invention
  • FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for a glucose sensor as shown in Example 1;
  • FIG. 3 is a graph illustrating the response of glucose sensors made as shown in Example 2, demonstrating the stability of such sensors after storage;
  • FIG. 4 is a graph comparing the response of glucose sensors, made in accordance with an embodiment of the invention featuring a spacer layer as in Example 3. to blood doped with glucose to give levels near the same concentrations as the standard solutions;
  • FIG. 5 is a graph illustrating the response of a lactate sensor made as in
  • FIG. 6 is a graph illustrating the linearity of fluorescence signal response to various levels of lactate for the lactate sensor of Example 4.
  • FIG. 7 is a graph illustrating the response of a cholesterol sensor made as shown in Example 5;
  • FIG. 8 is a schematic representation of a test apparatus for measuring an output signal amplitude of a luminescent optical sensor as described herein;
  • FIG. 9 is a graph illustrating the response of a creatinine sensor made as shown in Example 6; and FIG. 10 is a graph illustrating the proportional fluorescence signal response to various levels of creatinine for the creatinine sensors of Example 6.
  • Polymeric sensing layer refers to articles such as membranes or thin detection layers made of a composition which exhibits the quenching of luminescent energy by a gas such as oxygen (O 2 ), and can be used for quantitative and qualitative determination of the gas concentration in the environment being measured.
  • the sensing layer or membrane comprises a polymeric material containing at least one luminescent dye species preferably well-dispersed in the polymeric material.
  • Luminescence means light emitted from a molecule by radiative dissipation of energy from an electronically excited state.
  • Fluorescence means luminescence resulting from the transition between states of identical multiplicity, typically between the lowest excited singlet state and the singlet ground state of the molecule.
  • Phosphorescence means luminescence resulting from the transition between states of differing multiplicity, typically between the lowest excited triplet state and the singlet ground state.
  • Light-transmissive materials refers to materials preferably transmitting at least about 95% of electromagnetic radiation used to induce electronic excitations in luminescent material which result in emissions, more preferably at least about 99%o as measured by the transmission mode.
  • FIG. 1 depicts an embodiment of an optical sensor 20 in accordance with the disclosure in simplified cross-sectional view.
  • Sensor 20 comprises (from top to bottom) a rapidly hydrating gas-permeable cover layer 10; an enzymatic layer 11 containing an oxidative enzyme also in a water permeable and oxygen-permeable matrix; an oxygen sensing layer 12 containing luminescent dye in a light- transmissive. oxygen-permeable matrix: and a light-transmissive substrate 13. Further description of each layer is set forth below.
  • the light transmissive substrate 13 is preferably supplied to provide a surface for deposition of the other layers of the oxidative enzyme sensor. It must be light transmissive to allow the excitation radiation from a source situated on the uncoated side of the substrate to pass to the oxygen sensing layer 12, and the luminescent energy emitted from the oxygen sensing layer 12 pass back to the detection optics also situated on the uncoated side of the substrate.
  • the substrate should have a relatively low permeability to gases, especially oxygen, so as not to significantly influence the response of the oxygen sensing layer.
  • An exemplary and nonlimiting list of suitable substrates includes MYLAR*; polyethyleneterephthalate (PET); SARAN ® : and glass.
  • the substrate may be flexible or rigid, according to the particular demands of the desired end use.
  • the light-transmissive substrate is preferably polymeric and has a permeability of at most about 0.05 Barrers. more preferably at most about 0.005 Barrers, and most preferably at most about 0.0005 Barrers, as measured by the methods disclosed inJ. Membrane Sci. 9. 53 (1981).
  • Other suitable materials will be apparent to those of ordinary skill in the art and are intended to be within the scope of the present invention..
  • the oxygen sensing layer 12 contains luminescent dye in a light-transmissive. oxygen-permeable matrix. Any luminescent dyes capable of excitation, oxygen- quenchable emission, and which may be readily dispersed within the chosen matrix material, may be used.
  • Dyes which may be used in the present invention include, but are not limited to: metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions complexed with 2,2 -bipyridine; 1.10- phenanthroline; 4,7-diphenyl-l,10-phenanthroline; 4,7-dimethyl-l,10- phenanthroline; 4,7-disulfonated-diphenyl- 1 , 10-phenanthroline: 5-bromo- 1.10- phenanthroline; 5-chloro-1.10-phenanthroline; 2-2' bi-2-thiazoline; 2.2'-bithiazole.
  • metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions complexed with 2,2 -bipyridine 1.10
  • a-diimine ligands as disclosed in. e.g., U.S. Patent No. 4,752,115 and U.S. Patent No. 5,030,420; and porphyrin. chlorin or phthalocyanine complexes of VO 2 ⁇ . Cu 2 ⁇ Zn 2 ⁇ Pt 2* and Pd 2 such as is disclosed in U.S. Patent Nos. 4.810,655 and 5.043.286 and International application number PCT/EP97/03915.
  • a particular fluorescent dye material may be synthesized for a particular use with a given polymeric material based on the desired K s , (i.e.. Stern-Volmer constant) of the polymeric sensing membrane.
  • luminescent dye molecules which may be used include tris-(4,7-diphenyl-1.10-phenanthroline) Ru (II); octaethyl-Pt-porphyrin; octaethyl-Pt-porphyrin ketone; tetrabenzo-Pt-porphyrin; tetraphenyl-Pt-porphyrin: meso-tetraphenyl-tetrabenzo-Pt-poiphyrin; tetracyclohexenyl-Pt-porphyrin; octaethyl- Pt-chlorin; and tetraphenyl-Pt-chlorin.
  • the light-transmissive. oxygen-permeable matrices may comprise a copolymer made by selecting a first homopolymer comprised of first monomeric units, the first homopolymer having a first oxygen permeability value; selecting a second homopolymer comprised of second monomeric units, the second homopolymer having a second oxygen permeability value that is higher than the first permeability value; and copolymerizing the first and second monomeric units to obtain a copolymer having an intermediate oxygen permeability value, i.e.. between the first and second permeabilites values, the intermediate permeability providing the desired permeability for the desired oxygen sensing formulation, such as described in copending and commonly assigned U.S.
  • the oxygen sensing layer may further comprise a particulate filler material, in an amount effective to prevent the influence of changes in the sample absorbance and reflectance characteristics as disclosed in United States application number 09/009,914 and incorporated herein by reference.
  • the filler material appears to effectively eliminate light transmission through the sensor. Inclusion of the scattering filler is particularly advantageous for measurements involving luminescence amplitude or amplitude ratios. Accordingly, particles of, e.g., TiO : , zinc oxide, antimony trioxide, barium sulfate, magnesium oxide, and mixtures thereof, and in particular.
  • TiO 2 or BaSO 4 may be added in a range of 0 to about 95 wt% (based on the total weight of the oxygen sensing layer material), preferably 1 to 50wt%o. and more preferably 5 to 50wt%.
  • the oxygen sensing layer 12 is deposited, preferably, as a continuous layer, e.g., as a membrane, on light-transmissive substrate 13. Standard coating techniques known in the art. such as described in the Examples herein, may be used.
  • the enzymatic layer 11 includes an oxygen consuming or oxidase based enzyme in an oxygen-permeable matrix which is rapidly hydrated and, which is deposited on the oxygen-sensing layer 12.
  • Rapidly hydrating is meant that water is absorbed rapidly, to enable ions and small charged or water soluble molecules to diffuse through the membrane at about the diffusion speed of the water.
  • Rapidly hydrating materials which may be used to embed the enzyme in the enzyme layer include poly (vinyl alcohol) or (PVOH), crosslinked poly(vinyl alcohol) or (x-
  • the matrix of the enzyme layer 11 should, after hydration. be freely permeable to water and to the substrates of the oxidase enxyme e.g. oxygen and glucose for example, but it is not necessary that the matrix be light-transmissive.
  • the enzymatic layer need not also function as a "light shield", i.e., attenuate the effects of sample light scattering as described hereinabove.
  • the enzymatic layer can be specifically optimized to pass substrates and products, e.g., glucose lactate creatinine and oxygen, to the immobilized enzymes in the enzymatic layer, and preserve the enzymes in an active state.
  • the optical enzyme-based sensors of this disclosure are useful for measuring the concentration of analytes which are substrates of the immobilized oxidative enzymes.
  • Such enzymes include, without limitation, glucose oxidase. cholesterol oxidase, lactate oxidase and sarcosine oxidase.
  • the enzymatic layer may also comprise an enzyme mixture, such as an enzyme cascade, which allows for the detection of analytes which cannot directly, practically or possibly be the subject of enzymatic oxidation, such as creatinine.
  • Creatinine is an end product of nitrogen metabolism. In healthy individuals, creatinine is transported from blood to urine by the kidney glomeruli and then excreted in the urine without reabsorption. As such, creatinine is an important diagnostic index of kidney function and muscle diseases.
  • creatinine amidohydrase (“CA”)
  • creatine amidinohydrolase (“CF “ )
  • SO sarcosine oxidase
  • the depletion of oxygen or (O 2 ) is measurable by the oxygen sensing layer.
  • the amount of creatinine in the sample (being directly proportional to the amount of sarcosine oxidized) may be quantitatively determined.
  • Another embodiment of the present invention includes a rapidly hydrating cover or spacer layer 10 over the enzymatic layer 11.
  • Cover layer 10 ensures more accurate oxygen readings, i.e., those which are not skewed by oxygen concentration effects caused by red blood cell contact with the sensor.
  • red blood cells RBCs
  • the principal of operation of the present application is based on the oxidization, e.g., of available glucose in the blood sample by the immobilized glucose oxidase (i.e., the detection of oxygen is directly correlated to the glucose concentration), the depletion of oxygen proximate to the membrane will be high.
  • red blood cells in contact with the sensor will respond to the low oxygen level at the enzyme layer surface and release their bound oxygen, thus skewing the results obtained.
  • provision of a spacer layer 10 over the enzymatic layer 11 ensures that any oxygen released from the RBCs that are proximate to the spacer layer 10 is forced to follow a longer diffusion path than the dissolved oxygen from the blood plasma brought into the membrane sensor under short term “wet up” and normal measurement conditions.
  • the RBCs are therefore, through equilibrium concentration effects, effectively delayed or prevented from "dumping" their payload of oxygen into the membrane to counter the loss of oxygen immediately adjacent to the oxygen sensor layer.
  • Suitable material for the spacer layer includes poly(vinyl alcohol), which may be preferably crosslinked for chemical and physical durability.
  • Other suitable materials include any of the rapidly hydrating materials which may be used in used in the enzyme layer 11 itself.
  • FIG. 8 describes a suitable device for measuring the luminescent amplitude response of optical sensors 20 in the present invention.
  • the measurement apparatus 140 is comprised of a flow cell assembly 60 and a source and detector sub-system 100.
  • LED source 152 and lens 154 direct excitation light through filter 162 into one leg 182 of fiber optic splitter 180 (e.g., from American Laubscher Corp., Farmingdale. NY).
  • the luminescent light signal returning from the sensor 20 through fiber cable 80 and leg 184 is passed through filter 168 and aperture 158 before detection by photodiode 172 (e.g., from Hamamatsu Corporation. Bridgewater, NJ).
  • the output current of emission detector 172 is amplified with a preamplifier 174, such as a Stanford Research SR570 current preamplifier (Stanford Research Systems, Inc., Sunnyvale, CA), and converted to a voltage and recorded for use in analysis.
  • a preamplifier 174 such as a Stanford Research SR570 current preamplifier (Stanford Research Systems, Inc., Sunnyvale, CA)
  • the luminescent material 2 employing a different dye, such as octaethyl-Pt-porphyrin (OEP) as the luminescent material 2.
  • OEP octaethyl-Pt-porphyrin
  • the sensor detection layer 14 of optical sensor 20 is brought in contact with the sample by means of flow cell assembly 60, the optical emission signal that is generated and subsequently conveyed by fiber optic 80 to the source and detector subsystem 100 will be representative of the luminescent amplitude response.
  • the apparatus described in U.S. Patent Application No. 08/617.714. The following illustrative and nonlimiting examples are intended to demonstrate certain aspects of the present invention.
  • EXA M PLE 1 Glucose sensors were made in several steps.
  • THF tetrahydrofuran
  • a form was made by separating the faces of two glass plates about 2mm apart and providing a rubber sealing gasket therebetween, providing a space in the gasket to allow material to be added to the form.
  • the form was filled with about 32g of the above solution and heated to 60° C for 42 hours in a dry box flushed with nitrogen. The mixture was polymerized to form a solid, then the material was removed and dissolved in about 150ml of chloroform, glass filtered, and precipitated by adding the chloroform solution to 4 /of methanol. The precipitate was dried in a vacuum at 40°C for three days.
  • an enzymatic layer comprising glucose oxidase was made and deposited onto the oxygen sensing layer as follows. 2mg of glucose oxidase was dissolved in 200mg of deionized water. 1.8g of a methanol solution of a random copolymer made from starting monomers N,N-dimethylacrylamide (15%>) and N-tert- butylacrylamide monomers was added to the glucose oxidase solution, to provide a homogenous, pale yellow solution upon vortexing. The enzyme layer was formed by spin casting the pale yellow solution on the oxygen sensing layer for 20 seconds at 2000 RPM. The finished sensors were dried at room temperature under vacuum for three hours before testing. FIG.
  • FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for the sensor. The response stabilized after about 20 minutes of testing, and no enzyme loss corresponding to signal loss was observed after about two hours of testing after wet up had occurred.
  • EXAM PL E 2 Another embodiment of a glucose sensor was made in much the same manner as in Example 1 except that the enzyme layer was prepared by combining 2g of an aqueous solution of 13%) "crosslinker PVOH” (poly(vinyl alcohol), including N- methyl-4(-formalstyryl)pyridinium crosslinking agent) (Polysciences Inc.), 2mg of glucose oxidase, and 1 g deionized water to form the solution from which the enzyme layer was spin cast onto the oxygen sensing layer-coated substrate as above.
  • the glucose sensors were placed in a UV box for 10 minutes to crosslink the PVOH, removed, and stored under vacuum overnight at room temperature. The sensors were stored in uncovered, Petri dishes in a drawer for three and one half months, whereupon sensor response, wet-up, and stability were tested as above.
  • FIG. 3 illustrates the test results for example 2. Testing was performed with the optical instrument described in FIG. 8. The glucose sensors, despite the storage conditions, showed excellent activity when exposed to varying levels of glucose. The response was found to be comparable to the sensors made in Example 1 and actually a more rapid rate of oxygen uptake per amount of enzyme used was found in comparison to the sensors made with the acrylamide matrix.. Also the wet up period was found to be nearly instantaneous as dry sensors gave similarly fast kinetics on the first aqueous sample addition.
  • EXAM PLE 3 To demonstrate the benefits provided by the spacer layer disclosed herein, the glucose sensors made as in Example 1 were provided with spacer layers as follows. A layer of crosslinked PVOH was laid down in stripes from a solution prepared by mixing 250mg of the crosslinker PVOH solution with 750mg of a 5% aqueous solution of PVOH (average molecular weight of the polymer chains 124,000 to 186,000). The stripes were allowed to dry on the benchtop for a few hours before UV curing and vacuum storage. Testing was performed with the optical instrument described in FIG. 8. with a preamplifier 174 sensitivity of lOOpA/V. In this case a single shot protocol was used where a glucose containing blood sample was passed over a hydrated sensor. As illustrated in FIG. 4, blood has very little effect on suppressing the initial response of the glucose sensors when measured within the first half minute. Rather, the increasing glucose level gives rise to an increased rate of oxygen consumption evidenced by the rapidly rising luminescence signal level. EXA MPLE 4
  • a lactate sensor was made in much the same manner as example 2 above.
  • the enzyme layer solution was prepared by combining 2g of lactate oxidase, lg of crosslinker PVOH solution, lg of a 7% aqueous solution of PVOH, and lg of deionized water.
  • the sensors were tested as above and the data are presented in FIGs. 5 and 6.
  • FIGs. 5 and 6 demonstrate the good response and linearity of these sensors.
  • EXA MPLE 5 Sensors comprising cholesterol oxidase in the enzyme layer were made generally as above to produce a cholesterol sensor. The response curve was measured as above and the data are shown in the graph of FIG. 7. EXAMPLE 6
  • An optical sensor for measuring creatinine was prepared using the same basic procedures outlined in Examples 1 and 2 for making enzyme sensors except that 2 mg of the dye /wes ⁇ -tetraphenyl-tetrabenzo-Pt-porphyrin (mTPTBP) was substituted in place of octaethyl-Pt-porphyrin (OEP) in making the oxygen sensing layer.
  • mTPTBP dye /wes ⁇ -tetraphenyl-tetrabenzo-Pt-porphyrin
  • OEP octaethyl-Pt-porphyrin
  • An enzymatic layer was prepared by adding 13mg creatinine amidohydrase ("CA”), 20mg creatine amidinohydrolase (“CI”), and 23mg sarcosine oxidase ("SO”), to lmg of 7% aqueous solution of PVOH. This solution was spin coated onto the oxygen-sensing layer residing on a transparent substrate, and which had been previously prepared. A third spacer or cover layer was spin coated onto the enzymatic layer from a 10%> methanol solution of polyhydroxyethylmethacrylate, whereupon the sensor was cured by drying in a fume hood under ambient conditions.
  • CA creatinine amidohydrase
  • CI creatine amidinohydrolase
  • SO sarcosine oxidase
  • the sensors were tested by exposing the sensor to increasing levels of creatinine ranging from 2.5 mg/dl, 5.0 mg/dl. 12.5 mg/dl. 25 mg/dl and finally 50 mg/dl and interspersed with 0.05 M phosphate buffer samples containing no creatinine..
  • the excitation wavelength used for the sensors was 612 nm while the luminous intensity at 775 nm was measured on a model LS50-b Spectrofluorimeter (available from Perkin Elmer. Norwlk CT) and equipped with a flow cell to hold the sensors and samples
  • the actual luminescence response for such a sensor is presented in FIG. 9 and shows that the response is rapid and proportional to increasing levels of creatinine.
  • the plot in FIG. 10 shows the response of several such creatinine sensors.

Abstract

The invention discloses enzyme-based optical sensors for detecting blood components which are substrates for oxidative enzymes, the sensors advantageously employing a multiple-layer structure featuring a thin, rapidly responding, optical, oxygen sensing layer. The sensors comprise, in order, a) an enzymatic layer containing an oxidative enzyme or enzyme cascade in a water and oxygen-permeable matrix; b) an oxygen sensing layer containing luminescent dye in a light-transmissive, oxygen-permeable matrix; and which is preferably deposited onto c) a light-transmissive substrate. Embodiments of the invention may further include a rapidly hydrating gas-permeable cover, or spacer, layer deposited over the enzymatic layer. A particulate filler material may be included in an effective amount in the oxygen sensing layer to reduce sample light scattering effects. The sensors of the disclosure may be used to detect creatinine and other enzyme-oxidizable analytes such as glucose, lactate or cholesterol, and may be made easily using standard coating techniques known in the art. These sensors are suitable for multiple analyses, but the materials and methods used allow the sensors to be disposable as well, allowing their wide use in medical and analytical applications.

Description

OPTICAL OXIDATIVE ENZYME-BASED SENSORS
BACKGROUND OF THE INVENTION This invention generally relates to instrumentation for sensing various blood analytes, and more particularly towards optical sensors for detecting blood components which are substrates for oxidative enzymes.
Various sensors have been described in the art for measuring the presence of a substrate which may be enzymatically oxidized. Permanent or multiple use sensors have been made, for example, as in U. S. Patent No. 5,494,562, disclosing an electrochemical glucose sensor wherein the enzyme glucose oxidase is co- immobilized in a platinized carbon paste in contact with an electrode. The paste is further covered with a semipermeable porous polymer to permit the movement of hydrated glucose and oxygen gas to the paste, where the active enzyme converts these substrates to peroxide and gluconate. The polarized electrode then delivers a current and the reoxidation of peroxide to oxygen may be measured amperometrically. Examples of other amperometric sensor technologies have been described in U. S. Patent Nos. 4,680,268, 5,352,348, and 5,298,144. These sensors are disadvantageous for use in disposable applications, because they were designed to function in a multiuse format with an elaborate instrument system, and they employ expensive materials and methods of manufacture as well as requiring wet up and calibration before use.
Another example of permanent or multiple use sensors, using fiber optic glucose sensors, is disclosed in U. S. Patent No. 4,974,929, describing a chamber filled with an oxygen quenchable dye at the end of a fiber surrounded by a double jacketed wall. Sandwiched between the wall jackets is a crosslinked polymer layer containing the enzyme glucose oxidase. The glucose and oxygen consumption at the cylinder wall lowers oxygen diffusion into the cylinder space. This sensor requires a fair degree of manual assembly and is also not suitable for inexpensive, routine single use measurement applications. Each sensor must also be individually calibrated before use, and employs a large cylindrical volume for dye equilibration and accordingly suffers in response speed due to the requirement for bulk equilibration effects. Disposable or "one-shot" sensors, on the other hand, have been disclosed also, such as the colorimetric sensor set forth in U. S. Patent No. 5,208.147. Disposable dry reagent strips, e.g., U.S. Patent Nos. 3,992,158, 4,689.309, and 5,520.883. were developed specifically for single use applications. In operation, the sample hydrates the test strip and reagents are consumed in the development of a colorimetric change based on peroxide chemistries. They can be stored dry, are ready to use on demand, and find use in "wet" blood or serum chemistry, where the strips become saturated during use. However, the hydration and depletion of reactive chemical reagents in these strips effectively prevents their re-use. Handling and biohazard disposal of the many individually used test elements that would routinely be generated is a drawback. In the development of optical sensors which are inexpensive to manufacture and may be used in a rapid point of care setting, optical coatings and membranes containing luminescent dyes on light-transmissive substrates for the detection and measurement of O2 in blood, have been developed and are incorporated by reference as United State application number 08/617,714. An advantage of these sensors is that it is possible to bring the sensor into intimate contact with a blood sample while transmitting excitation light through the transparent substrate from the "back" side of the sensor, to enable subsequent detection of the luminescent radiation emitted from the luminescent dye from the same side of the sensor. Such coatings or membranes are quite thin, typically l-5μm for pH and oxygen sensors, and show an extremely rapid response.
However, the application of such thin optical coating-based technologies to the area of glucose determination is not straightforward. Firstly, measurements of oxygen uptake in blood are directly affected by the oxygen buffering capacity of a blood sample itself. If blood is introduced into a measurement system containing an optical sensor, red blood cells (RBCs) will be in contact with the sensor. Since the principal of operation of optical glucose sensors is based on oxidization of available glucose in the blood sample by immobilized glucose oxidase in the sensor (i.e.. the detection of oxygen is directly correlatable to the glucose concentration), the depletion of oxygen proximate to the membrane will be high. As such, red blood cells (RBCs) in contact with the sensor will sense the low oxygen concentration at the membrane surface and respond by releasing bound oxygen, thus acting as an oxygen buffer and skewing the results obtained.
Secondly, a large fraction of the excitation light (in some cases as much as 90- 95%) as well as the luminescent energy emitted from the sensing layer from these thin membranes passes into the sample (blood) to be absorbed, scattered, or reflected back into the sensing layer and into the detection optics. These effects can. together, produce a four-fold change in luminescence signal level between a perfectly absorbing and perfectly reflecting sample, thus presenting a significant source of uncertainty in the use of luminescent optical sensors, particularly if used in the simplest amplitude readout mode. Accordingly, it has been desired to obtain optical sensors for measuring oxidizable analytes which are inexpensive enough to design and manufacture to make them disposable, avoid the aforementioned drawbacks, and also allow multiple uses if desired.
S UM MA RY OF TH E INV ENTI ON The presently-disclosed invention relates to enzyme-based optical sensors for detecting blood components which are substrates for oxidative enzymes, the sensors advantageously employing a multiple-layer structure featuring a thin, rapidly responding, optical, oxygen sensing layer. In one embodiment, the sensor comprises, in order, a) a rapidly hydrating gas-permeable cover, or spacer, layer; b) an enzymatic layer containing an oxidative enzyme also in a water and oxygen-permeable matrix; c) an oxygen sensing layer containing luminescent dye in a light-transmissive. oxygen- permeable matrix; and, preferably, d) a light-transmissive substrate. In another embodiment the oxygen sensing layer further comprises an effective amount of a particulate filler material to reduce or eliminate sample light scattering effects. The inventive sensors may be used to detect glucose and other enzyme-oxidizable analytes such as lactate or cholesterol. In yet another embodiment, the sensor additionally comprises, an enzyme "cascade" system instead of a single oxidative enzyme in the enzymatic layer containing a water and oxygen-permeable matrix. These sensors may be employed to detect analytes such as creatinine. which may not be enzymatically oxidized by a single enzyme but require several enzymatic steps to generate an oxidizable analyte derivative.
The sensors of this disclosure may be made easily using standard coating techniques known in the art. The sensors are adaptable for reuse, but available materials and methods allow the sensors to be disposable as well, permitting their wide use in medical and analytical applications.
B RI EF DESCRI PTI ON O F TH E DRA WING S The invention will be further understood by reference to the disclosure and the attached drawings, of which:
FIG. 1 is a cross-sectional view of a sensor in accordance with one embodiment of the presently disclosed invention;
FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for a glucose sensor as shown in Example 1;
FIG. 3 is a graph illustrating the response of glucose sensors made as shown in Example 2, demonstrating the stability of such sensors after storage;
FIG. 4 is a graph comparing the response of glucose sensors, made in accordance with an embodiment of the invention featuring a spacer layer as in Example 3. to blood doped with glucose to give levels near the same concentrations as the standard solutions; FIG. 5 is a graph illustrating the response of a lactate sensor made as in
Example 4;
FIG. 6 is a graph illustrating the linearity of fluorescence signal response to various levels of lactate for the lactate sensor of Example 4;
FIG. 7 is a graph illustrating the response of a cholesterol sensor made as shown in Example 5; FIG. 8 is a schematic representation of a test apparatus for measuring an output signal amplitude of a luminescent optical sensor as described herein;
FIG. 9 is a graph illustrating the response of a creatinine sensor made as shown in Example 6; and FIG. 10 is a graph illustrating the proportional fluorescence signal response to various levels of creatinine for the creatinine sensors of Example 6.
DETA I LED DESCRIPTI ON OF THE INV ENTION "Polymeric sensing layer", as used herein, refers to articles such as membranes or thin detection layers made of a composition which exhibits the quenching of luminescent energy by a gas such as oxygen (O2), and can be used for quantitative and qualitative determination of the gas concentration in the environment being measured. The sensing layer or membrane comprises a polymeric material containing at least one luminescent dye species preferably well-dispersed in the polymeric material. "Luminescence", as used herein, means light emitted from a molecule by radiative dissipation of energy from an electronically excited state. "Fluorescence", as used herein, means luminescence resulting from the transition between states of identical multiplicity, typically between the lowest excited singlet state and the singlet ground state of the molecule. "Phosphorescence", as used herein, means luminescence resulting from the transition between states of differing multiplicity, typically between the lowest excited triplet state and the singlet ground state.
"Light-transmissive materials", as used herein, refers to materials preferably transmitting at least about 95% of electromagnetic radiation used to induce electronic excitations in luminescent material which result in emissions, more preferably at least about 99%o as measured by the transmission mode.
FIG. 1 depicts an embodiment of an optical sensor 20 in accordance with the disclosure in simplified cross-sectional view. Sensor 20 comprises (from top to bottom) a rapidly hydrating gas-permeable cover layer 10; an enzymatic layer 11 containing an oxidative enzyme also in a water permeable and oxygen-permeable matrix; an oxygen sensing layer 12 containing luminescent dye in a light- transmissive. oxygen-permeable matrix: and a light-transmissive substrate 13. Further description of each layer is set forth below.
The light transmissive substrate 13 is preferably supplied to provide a surface for deposition of the other layers of the oxidative enzyme sensor. It must be light transmissive to allow the excitation radiation from a source situated on the uncoated side of the substrate to pass to the oxygen sensing layer 12, and the luminescent energy emitted from the oxygen sensing layer 12 pass back to the detection optics also situated on the uncoated side of the substrate. The substrate should have a relatively low permeability to gases, especially oxygen, so as not to significantly influence the response of the oxygen sensing layer. An exemplary and nonlimiting list of suitable substrates includes MYLAR*; polyethyleneterephthalate (PET); SARAN®: and glass. The substrate may be flexible or rigid, according to the particular demands of the desired end use. The light-transmissive substrate is preferably polymeric and has a permeability of at most about 0.05 Barrers. more preferably at most about 0.005 Barrers, and most preferably at most about 0.0005 Barrers, as measured by the methods disclosed inJ. Membrane Sci. 9. 53 (1981). Other suitable materials will be apparent to those of ordinary skill in the art and are intended to be within the scope of the present invention..
The oxygen sensing layer 12 contains luminescent dye in a light-transmissive. oxygen-permeable matrix.. Any luminescent dyes capable of excitation, oxygen- quenchable emission, and which may be readily dispersed within the chosen matrix material, may be used. Dyes which may be used in the present invention include, but are not limited to: metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions complexed with 2,2 -bipyridine; 1.10- phenanthroline; 4,7-diphenyl-l,10-phenanthroline; 4,7-dimethyl-l,10- phenanthroline; 4,7-disulfonated-diphenyl- 1 , 10-phenanthroline: 5-bromo- 1.10- phenanthroline; 5-chloro-1.10-phenanthroline; 2-2' bi-2-thiazoline; 2.2'-bithiazole. and other a-diimine ligands as disclosed in. e.g., U.S. Patent No. 4,752,115 and U.S. Patent No. 5,030,420; and porphyrin. chlorin or phthalocyanine complexes of VO2^. Cu2\ Zn2\ Pt2* and Pd2 such as is disclosed in U.S. Patent Nos. 4.810,655 and 5.043.286 and International application number PCT/EP97/03915. Note that a particular fluorescent dye material may be synthesized for a particular use with a given polymeric material based on the desired Ks, (i.e.. Stern-Volmer constant) of the polymeric sensing membrane. Specific luminescent dye molecules which may be used include tris-(4,7-diphenyl-1.10-phenanthroline) Ru (II); octaethyl-Pt-porphyrin; octaethyl-Pt-porphyrin ketone; tetrabenzo-Pt-porphyrin; tetraphenyl-Pt-porphyrin: meso-tetraphenyl-tetrabenzo-Pt-poiphyrin; tetracyclohexenyl-Pt-porphyrin; octaethyl- Pt-chlorin; and tetraphenyl-Pt-chlorin.
In an embodiment, the light-transmissive. oxygen-permeable matrices may comprise a copolymer made by selecting a first homopolymer comprised of first monomeric units, the first homopolymer having a first oxygen permeability value; selecting a second homopolymer comprised of second monomeric units, the second homopolymer having a second oxygen permeability value that is higher than the first permeability value; and copolymerizing the first and second monomeric units to obtain a copolymer having an intermediate oxygen permeability value, i.e.. between the first and second permeabilites values, the intermediate permeability providing the desired permeability for the desired oxygen sensing formulation, such as described in copending and commonly assigned U.S. Patent Application Number 09/010,161, Attorney Docket No. CCD-239XX, the entire disclosure of which is incorporated herein by reference. In another embodiment, the oxygen sensing layer may further comprise a particulate filler material, in an amount effective to prevent the influence of changes in the sample absorbance and reflectance characteristics as disclosed in United States application number 09/009,914 and incorporated herein by reference. The filler material appears to effectively eliminate light transmission through the sensor. Inclusion of the scattering filler is particularly advantageous for measurements involving luminescence amplitude or amplitude ratios. Accordingly, particles of, e.g., TiO:, zinc oxide, antimony trioxide, barium sulfate, magnesium oxide, and mixtures thereof, and in particular. TiO2 or BaSO4 may be added in a range of 0 to about 95 wt% (based on the total weight of the oxygen sensing layer material), preferably 1 to 50wt%o. and more preferably 5 to 50wt%. The oxygen sensing layer 12 is deposited, preferably, as a continuous layer, e.g., as a membrane, on light-transmissive substrate 13. Standard coating techniques known in the art. such as described in the Examples herein, may be used.
The enzymatic layer 11 includes an oxygen consuming or oxidase based enzyme in an oxygen-permeable matrix which is rapidly hydrated and, which is deposited on the oxygen-sensing layer 12. (By "rapidly hydrating" is meant that water is absorbed rapidly, to enable ions and small charged or water soluble molecules to diffuse through the membrane at about the diffusion speed of the water.) Rapidly hydrating materials which may be used to embed the enzyme in the enzyme layer include poly (vinyl alcohol) or (PVOH), crosslinked poly(vinyl alcohol) or (x-
PVOH), hydrophylic polyurethanes. polyacrylamides or gelatin.. The matrix of the enzyme layer 11 should, after hydration. be freely permeable to water and to the substrates of the oxidase enxyme e.g. oxygen and glucose for example, but it is not necessary that the matrix be light-transmissive. One advantage of the sensors of this disclosure is that the enzymatic layer need not also function as a "light shield", i.e., attenuate the effects of sample light scattering as described hereinabove. Instead, the enzymatic layer can be specifically optimized to pass substrates and products, e.g., glucose lactate creatinine and oxygen, to the immobilized enzymes in the enzymatic layer, and preserve the enzymes in an active state. The optical enzyme-based sensors of this disclosure are useful for measuring the concentration of analytes which are substrates of the immobilized oxidative enzymes. Such enzymes include, without limitation, glucose oxidase. cholesterol oxidase, lactate oxidase and sarcosine oxidase.
The enzymatic layer may also comprise an enzyme mixture, such as an enzyme cascade, which allows for the detection of analytes which cannot directly, practically or possibly be the subject of enzymatic oxidation, such as creatinine. Creatinine is an end product of nitrogen metabolism. In healthy individuals, creatinine is transported from blood to urine by the kidney glomeruli and then excreted in the urine without reabsorption. As such, creatinine is an important diagnostic index of kidney function and muscle diseases. By providing an enzyme cascade system comprising, e.g., creatinine amidohydrase ("CA"), creatine amidinohydrolase ("CF"), and sarcosine oxidase ("SO"), creatinine is enzymatically converted to glycine, formaldehyde and hydrogen peroxide as follows: creatinine + H2O > creatine
CA creatine + H2O > sarcosine + urea
CI sarcosine + H,O + O, > glycine + HCHO + H2O, .
SO
In the final reaction, the depletion of oxygen or (O2 ) is measurable by the oxygen sensing layer. Thus, the amount of creatinine in the sample (being directly proportional to the amount of sarcosine oxidized) may be quantitatively determined.
Another embodiment of the present invention includes a rapidly hydrating cover or spacer layer 10 over the enzymatic layer 11. Cover layer 10 ensures more accurate oxygen readings, i.e., those which are not skewed by oxygen concentration effects caused by red blood cell contact with the sensor. As blood is introduced into a system containing an optical sensor as disclosed herein, red blood cells (RBCs) will be in contact with the sensor, i.e., at cover layer 10. Since the principal of operation of the present application is based on the oxidization, e.g., of available glucose in the blood sample by the immobilized glucose oxidase (i.e., the detection of oxygen is directly correlated to the glucose concentration), the depletion of oxygen proximate to the membrane will be high. Without cover layer 10, red blood cells (RBCs) in contact with the sensor will respond to the low oxygen level at the enzyme layer surface and release their bound oxygen, thus skewing the results obtained. However, provision of a spacer layer 10 over the enzymatic layer 11 ensures that any oxygen released from the RBCs that are proximate to the spacer layer 10 is forced to follow a longer diffusion path than the dissolved oxygen from the blood plasma brought into the membrane sensor under short term "wet up" and normal measurement conditions. The RBCs are therefore, through equilibrium concentration effects, effectively delayed or prevented from "dumping" their payload of oxygen into the membrane to counter the loss of oxygen immediately adjacent to the oxygen sensor layer.
Accordingly, as the blood sample passes over sensor 20. the oxygen concentration in the blood sample remains unchanged for a period of time sufficient for measurement to take place. Suitable material for the spacer layer includes poly(vinyl alcohol), which may be preferably crosslinked for chemical and physical durability. Other suitable materials include any of the rapidly hydrating materials which may be used in used in the enzyme layer 11 itself.
In operation of the inventive sensors. FIG. 8 describes a suitable device for measuring the luminescent amplitude response of optical sensors 20 in the present invention. The measurement apparatus 140 is comprised of a flow cell assembly 60 and a source and detector sub-system 100. For the optical source and detector subsystem 100, LED source 152 and lens 154 direct excitation light through filter 162 into one leg 182 of fiber optic splitter 180 (e.g., from American Laubscher Corp., Farmingdale. NY). The luminescent light signal returning from the sensor 20 through fiber cable 80 and leg 184 is passed through filter 168 and aperture 158 before detection by photodiode 172 (e.g., from Hamamatsu Corporation. Bridgewater, NJ). The output current of emission detector 172 is amplified with a preamplifier 174, such as a Stanford Research SR570 current preamplifier (Stanford Research Systems, Inc., Sunnyvale, CA), and converted to a voltage and recorded for use in analysis.
For example, with the luminescent dye wesø-tetraphenyl--tetrabenzo-Pt- porphyrin ( m-TPTBP), a super bright orange LED (TLOH180P available from Marktech International Corp, Latham, NY) was used for source 152. An interference filter with a 580nm center wavelength and lOOnm half bandwidth (e.g.. from Omega Optical. Brattleboro. VT) was used for filter 162 and a 710 EFLP long wavelength pass filter for emission above 710nm (Omega Optical. Brattleboro. VT) was used for filter 168. Each individual sensor detection layer 14. employing a different dye, such as octaethyl-Pt-porphyrin (OEP) as the luminescent material 2. will typically require its own preferred LED source 152. excitation filter 162 and emission filter 168. When the sensor detection layer 14 of optical sensor 20 is brought in contact with the sample by means of flow cell assembly 60, the optical emission signal that is generated and subsequently conveyed by fiber optic 80 to the source and detector subsystem 100 will be representative of the luminescent amplitude response. For frequency-based measurements one may employ the apparatus described in U.S. Patent Application No. 08/617.714. The following illustrative and nonlimiting examples are intended to demonstrate certain aspects of the present invention.
EXA M PLE 1 Glucose sensors were made in several steps. In a first step, an oxygen sensing layer was prepared and coated on a light transmissive substrate as follows. Starting monomers were either recrystallized from bulk or freshly distilled to ensure purity. The comonomer mixture comprised of styrene (58%) and acrylonitrile (42%). and an effective amount, about 0.070g, of the initiator azo-fe-isobutyronitrile (MW=192.3) were dissolved in tetrahydrofuran (THF) to form a homogeneous solution. A form was made by separating the faces of two glass plates about 2mm apart and providing a rubber sealing gasket therebetween, providing a space in the gasket to allow material to be added to the form. The form was filled with about 32g of the above solution and heated to 60° C for 42 hours in a dry box flushed with nitrogen. The mixture was polymerized to form a solid, then the material was removed and dissolved in about 150ml of chloroform, glass filtered, and precipitated by adding the chloroform solution to 4 /of methanol. The precipitate was dried in a vacuum at 40°C for three days. 2mg of the dye octaethyl-Pt-porphyrin dye (OEP) and lOOmg of the styrene/acrylonitrile copolymer was dissolved in 1ml of tetrahydrofuran (THF) and a thin membrane was spin cast onto a clear MYLAR® substrate from 20 seconds at 2000 RPM..
In a second step an enzymatic layer comprising glucose oxidase was made and deposited onto the oxygen sensing layer as follows. 2mg of glucose oxidase was dissolved in 200mg of deionized water. 1.8g of a methanol solution of a random copolymer made from starting monomers N,N-dimethylacrylamide (15%>) and N-tert- butylacrylamide monomers was added to the glucose oxidase solution, to provide a homogenous, pale yellow solution upon vortexing. The enzyme layer was formed by spin casting the pale yellow solution on the oxygen sensing layer for 20 seconds at 2000 RPM. The finished sensors were dried at room temperature under vacuum for three hours before testing. FIG. 2 is a graph illustrating the linearity of fluorescence signal response to various levels of glucose in standard buffer solution for the sensor. The response stabilized after about 20 minutes of testing, and no enzyme loss corresponding to signal loss was observed after about two hours of testing after wet up had occurred.
EXAM PL E 2 Another embodiment of a glucose sensor was made in much the same manner as in Example 1 except that the enzyme layer was prepared by combining 2g of an aqueous solution of 13%) "crosslinker PVOH" (poly(vinyl alcohol), including N- methyl-4(-formalstyryl)pyridinium crosslinking agent) (Polysciences Inc.), 2mg of glucose oxidase, and 1 g deionized water to form the solution from which the enzyme layer was spin cast onto the oxygen sensing layer-coated substrate as above. The glucose sensors were placed in a UV box for 10 minutes to crosslink the PVOH, removed, and stored under vacuum overnight at room temperature. The sensors were stored in uncovered, Petri dishes in a drawer for three and one half months, whereupon sensor response, wet-up, and stability were tested as above.
FIG. 3 illustrates the test results for example 2. Testing was performed with the optical instrument described in FIG. 8. The glucose sensors, despite the storage conditions, showed excellent activity when exposed to varying levels of glucose. The response was found to be comparable to the sensors made in Example 1 and actually a more rapid rate of oxygen uptake per amount of enzyme used was found in comparison to the sensors made with the acrylamide matrix.. Also the wet up period was found to be nearly instantaneous as dry sensors gave similarly fast kinetics on the first aqueous sample addition.
EXAM PLE 3 To demonstrate the benefits provided by the spacer layer disclosed herein, the glucose sensors made as in Example 1 were provided with spacer layers as follows. A layer of crosslinked PVOH was laid down in stripes from a solution prepared by mixing 250mg of the crosslinker PVOH solution with 750mg of a 5% aqueous solution of PVOH (average molecular weight of the polymer chains 124,000 to 186,000). The stripes were allowed to dry on the benchtop for a few hours before UV curing and vacuum storage. Testing was performed with the optical instrument described in FIG. 8. with a preamplifier 174 sensitivity of lOOpA/V. In this case a single shot protocol was used where a glucose containing blood sample was passed over a hydrated sensor. As illustrated in FIG. 4, blood has very little effect on suppressing the initial response of the glucose sensors when measured within the first half minute. Rather, the increasing glucose level gives rise to an increased rate of oxygen consumption evidenced by the rapidly rising luminescence signal level. EXA MPLE 4
A lactate sensor was made in much the same manner as example 2 above. The enzyme layer solution was prepared by combining 2g of lactate oxidase, lg of crosslinker PVOH solution, lg of a 7% aqueous solution of PVOH, and lg of deionized water. The sensors were tested as above and the data are presented in FIGs. 5 and 6. FIGs. 5 and 6 demonstrate the good response and linearity of these sensors.
EXA MPLE 5 Sensors comprising cholesterol oxidase in the enzyme layer were made generally as above to produce a cholesterol sensor. The response curve was measured as above and the data are shown in the graph of FIG. 7. EXAMPLE 6
An optical sensor for measuring creatinine was prepared using the same basic procedures outlined in Examples 1 and 2 for making enzyme sensors except that 2 mg of the dye /wesø-tetraphenyl-tetrabenzo-Pt-porphyrin (mTPTBP) was substituted in place of octaethyl-Pt-porphyrin (OEP) in making the oxygen sensing layer. A thin oxygen sensing layer was first spin cast as a membrane onto a clear MYLAR® substrate. An enzymatic layer was prepared by adding 13mg creatinine amidohydrase ("CA"), 20mg creatine amidinohydrolase ("CI"), and 23mg sarcosine oxidase ("SO"), to lmg of 7% aqueous solution of PVOH. This solution was spin coated onto the oxygen-sensing layer residing on a transparent substrate, and which had been previously prepared. A third spacer or cover layer was spin coated onto the enzymatic layer from a 10%> methanol solution of polyhydroxyethylmethacrylate, whereupon the sensor was cured by drying in a fume hood under ambient conditions. The sensors were tested by exposing the sensor to increasing levels of creatinine ranging from 2.5 mg/dl, 5.0 mg/dl. 12.5 mg/dl. 25 mg/dl and finally 50 mg/dl and interspersed with 0.05 M phosphate buffer samples containing no creatinine.. The excitation wavelength used for the sensors was 612 nm while the luminous intensity at 775 nm was measured on a model LS50-b Spectrofluorimeter (available from Perkin Elmer. Norwlk CT) and equipped with a flow cell to hold the sensors and samples The actual luminescence response for such a sensor is presented in FIG. 9 and shows that the response is rapid and proportional to increasing levels of creatinine. The plot in FIG. 10 shows the response of several such creatinine sensors.
Having thus described certain embodiments of the invention, various alterations, modifications and improvements will readily occur to those skilled in the art. Such alterations, modifications and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the invention. For example, it is contemplated that additional or intervening layers which do not detract from the essential inventive concept are intended to be part of the present invention. Accordingly, the foregoing description is by way of example only and is not intended as limiting. The invention is limited only as defined in the following claims and their equivalents.

Claims

CLAIMSWhat is claimed is:
1. An oxidative enzyme sensor having an optical sensing membrane comprising, in order: a) an enzymatic layer containing an oxidative enzyme in a hydrateable and oxygen permeable matrix.; and b) an oxygen sensing layer containing luminescent dye in a light- transmissive, oxygen-permeable matrix wherein said enzymatic layer is disposed on said oxygen sensing layer.
2. The oxidative enzyme sensor of claim 1 further comprising a light- transmissive substrate wherein said oxygen sensing layer is disposed on said light transmissive substrate.
3. The oxidative enzyme sensor of claim 1 further comprising a rapidly hydrating gas-permeable cover layer disposed over the enzymatic layer.
4. The oxidative enzyme sensor of claim 1 wherein said oxygen sensing layer further comprises a particulate filler material in an effective amount to reduce sample light scattering effects.
5. The oxidative enzyme sensor of claim 2 further comprising a light source and a light detector disposed adjacent said light-transmissive substrate.
6. The oxidative enzyme sensor of claim 1 wherein said enzymatic layer contains an oxidative enzyme specific for substrates selected from the group consisting of glucose, lactate, malate. and cholesterol.
7. The oxidative enzyme sensor of claim 1, wherein said luminescent dye is selected from the group consisting of: ruthenium complexes; porphyrin derivatives; lanthanide complexes; tetrabenzo-Pt-porphyrin; tetraphenyl-Pt- porphyrin; octaethyl-Pt-porphyrin ketone; octaethyl-Pt-porphyrin: octaethyl- Pt-chlorin; tetraphenyl-Pt-chlorin; (4,7-diphenyl-l ,l-phenanthroline), Ru(II); ligand metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions with 2.2 -bipyridine. 1 , 10-phenanthroline, 4,7- diphenyl-(1.20-phenanthroline), 4,7-dimethyl-1.10-phenanthroline. 4.7- disulfonated-diphenyl- 1 , 10-phenanthroline. 5-bromo- 1.10-phenanthroline. 5- chloro- 1 , 10-phenanthroline, 2-2' bi-2-thiazoline. and 2,2'-bithiazole; meso- tetraphenyl-tetrabenzo-Pt-poφhyrin: mesø-tetraphenyl-tetrabenzo-Pt- poφhyrin (mTPTBP); and tetracyclohexenyl-/ne5O-tetraphenyl-Pt-poφhyrin (TCHPP).
8. The oxidative enzyme sensor of claim 4 wherein said particulate filler material is selected from the group consisting of TiO2 zinc oxide, antimony trioxide, barium sulfate, magnesium oxide, and mixtures thereof.
9. The oxidative enzyme sensor of claim 1 wherein said enzymatic layer contains an oxidative enzyme cascade.
10. The oxidative enzyme sensor of claim 9 wherein said oxidative enzyme cascade is specific for creatinine.
1 1. A method of making an oxidative enzyme sensor having an optical sensing membrane comprising, in order: a) preparing an oxygen sensing layer containing luminescent dye in a light-transmissive. oxygen-permeable matrix; and b) depositing an enzymatic layer on said oxygen sensing layer, said enzymatic layer containing an oxidative enzyme or oxidative enzyme cascade in an oxygen-permeable matrix.
12. The method of claim 11 further comprising the step of disposing said oxygen sensing layer on a light-transmissive substrate.
13. The method of claim 11 further comprising the step of depositing a rapidly hydrating gas-permeable cover layer on said enzymatic layer.
14. The method of claim 11 wherein said step of preparing further comprises introducing a particulate filler material in an effective amount to reduce sample light scattering effects.
15. The method of claim 1 1 wherein said step of depositing further comprises depositing said enzymatic layer containing an oxidative enzyme specific for substrates selected from the group consisting of glucose, lactate. and cholesterol.
16. The method of claim 1 1. wherein said luminescent dye is selected from the group consisting of: ruthenium complexes; poφhyrin derivatives; lanthanide complexes; tetrabenzo-Pt-poφhyrin; tetraphenyl-Pt-poφhyrin; octaethyl-Pt- poφhyrin ketone; octaethyl-Pt-poφhyrin; octaethyl-Pt-chlorin; tetraphenyl-Pt- chlorin; (4.7-diphenyl-l.l-phenanthroline)3 Ru(II); ligand metal complexes of ruthenium (II), osmium (II), iridium (III), rhodium (III) and chromium (III) ions with 2.2 -bipyridine, 1.10-phenanthroline, 4,7-diphenyl-(l,20- phenanthroline), 4,7-dimethyl- 1 , 10-phenanthroline, 4,7-disulfonated-diphenyl- 1 , 10-phenanthroline. 5-bromo- 1,10-phenanthroline, 5-chloro-l,10- phenanthroline, 2-2' bi-2-thiazoline, and 2.2'-bithiazole; meso-tetraphenyl- tetrabenzo-Pt-poφhyrin; eiO-tetraphenyl-tetrabenzo-Pt-poφhyrin (mTPTBP); and tetracyclohexenyl-me.s'ø-tetraphenyl-Pt-poφhyrin (TCHPP).
17. The method of claim 14 wherein said step of introducing comprises selecting said particulate filler material from the group consisting of TiO2, zinc oxide, antimony trioxide, barium sulfate. magnesium oxide, and mixtures thereof.
18. The method of claim 11 wherein said step of depositing further comprises depositing said enzymatic layer containing an oxidative enzyme cascade specific for creatinine.
PCT/IB1999/001451 1998-08-21 1999-08-19 Optical oxidative enzyme-based sensors WO2000011205A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU51883/99A AU5188399A (en) 1998-08-21 1999-08-19 Optical oxidative enzyme-based sensors
EP99936915A EP1112374A1 (en) 1998-08-21 1999-08-19 Optical oxidative enzyme-based sensors
JP2000566457A JP2002523733A (en) 1998-08-21 1999-08-19 Optical sensor based on oxidase
CA002340983A CA2340983A1 (en) 1998-08-21 1999-08-19 Optical oxidative enzyme-based sensors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/137,616 1998-08-21
US09/137,616 US6107083A (en) 1998-08-21 1998-08-21 Optical oxidative enzyme-based sensors

Publications (1)

Publication Number Publication Date
WO2000011205A1 true WO2000011205A1 (en) 2000-03-02

Family

ID=22478266

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB1999/001451 WO2000011205A1 (en) 1998-08-21 1999-08-19 Optical oxidative enzyme-based sensors

Country Status (6)

Country Link
US (1) US6107083A (en)
EP (1) EP1112374A1 (en)
JP (1) JP2002523733A (en)
AU (1) AU5188399A (en)
CA (1) CA2340983A1 (en)
WO (1) WO2000011205A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872573B2 (en) 2003-01-02 2005-03-29 Bayer Corporation Fluorescent creatinine assay
US7222024B2 (en) 2002-12-31 2007-05-22 Kuo-Jeng Wang Method for determining the concentration of blood glucose
US8320986B2 (en) 2003-04-04 2012-11-27 Transpacific Systems, Llc Method for determining the resolution of blood glucose
CN103091264A (en) * 2011-10-31 2013-05-08 爱科来株式会社 Analytical instrument and analytical method
US10947577B2 (en) 2012-02-16 2021-03-16 3M Innovative Properties Company Biological sterilization indicator devices and methods of use

Families Citing this family (155)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395506B1 (en) * 1991-04-18 2002-05-28 Becton, Dickinson And Company Device for monitoring cells
US7657297B2 (en) * 2004-05-03 2010-02-02 Dexcom, Inc. Implantable analyte sensor
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6331438B1 (en) 1999-11-24 2001-12-18 Iowa State University Research Foundation, Inc. Optical sensors and multisensor arrays containing thin film electroluminescent devices
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
EP1397068A2 (en) 2001-04-02 2004-03-17 Therasense, Inc. Blood glucose tracking apparatus and methods
US6960466B2 (en) 2001-05-31 2005-11-01 Instrumentation Laboratory Company Composite membrane containing a cross-linked enzyme matrix for a biosensor
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7033371B2 (en) 2001-06-12 2006-04-25 Pelikan Technologies, Inc. Electric lancet actuator
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
CA2448902C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US7699791B2 (en) 2001-06-12 2010-04-20 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
DE60234597D1 (en) 2001-06-12 2010-01-14 Pelikan Technologies Inc DEVICE AND METHOD FOR REMOVING BLOOD SAMPLES
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US10022078B2 (en) 2004-07-13 2018-07-17 Dexcom, Inc. Analyte sensor
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7002670B2 (en) * 2002-06-12 2006-02-21 Baxter International Inc. Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance
US7248912B2 (en) * 2002-10-31 2007-07-24 The Regents Of The University Of California Tissue implantable sensors for measurement of blood solutes
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US6999807B2 (en) * 2003-01-23 2006-02-14 Scimed Life Systems, Inc. pH measuring balloon
ES2347248T3 (en) 2003-05-30 2010-10-27 Pelikan Technologies Inc. PROCEDURE AND APPLIANCE FOR FLUID INJECTION.
WO2004107964A2 (en) 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
JP2005151972A (en) * 2003-07-10 2005-06-16 F Hoffmann La Roche Ag Nanoparticle for optical sensor
EP1502957B1 (en) * 2003-07-11 2008-08-27 F. Hoffmann-La Roche Ag Castable diffusion membrane for enzyme-based sensor application
CA2473069C (en) * 2003-07-11 2014-03-18 F. Hoffmann-La Roche Ag Castable diffusion membrane for enzyme-based sensor application
EP1648298A4 (en) * 2003-07-25 2010-01-13 Dexcom Inc Oxygen enhancing membrane systems for implantable devices
US20050176136A1 (en) * 2003-11-19 2005-08-11 Dexcom, Inc. Afinity domain for analyte sensor
US8282549B2 (en) 2003-12-09 2012-10-09 Dexcom, Inc. Signal processing for continuous analyte sensor
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US7494465B2 (en) 2004-07-13 2009-02-24 Dexcom, Inc. Transcutaneous analyte sensor
US20100168657A1 (en) 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US7519408B2 (en) 2003-11-19 2009-04-14 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US7276029B2 (en) 2003-08-01 2007-10-02 Dexcom, Inc. System and methods for processing analyte sensor data
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US7933639B2 (en) 2003-08-01 2011-04-26 Dexcom, Inc. System and methods for processing analyte sensor data
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US7198855B2 (en) * 2003-09-12 2007-04-03 Becton, Dickinson And Company Methods of surface modification of a flexible substrate to enhance cell adhesion
US20050059140A1 (en) * 2003-09-12 2005-03-17 Andrea Liebmann-Vinson Methods of surface modification to enhance cell adhesion
WO2005033659A2 (en) 2003-09-29 2005-04-14 Pelikan Technologies, Inc. Method and apparatus for an improved sample capture device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
EP2239567B1 (en) 2003-12-05 2015-09-02 DexCom, Inc. Calibration techniques for a continuous analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
DE602004028164D1 (en) * 2003-12-08 2010-08-26 Dexcom Inc SYSTEMS AND METHOD FOR IMPROVING ELECTROCHEMICAL ANALYTIC SENSORS
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8277713B2 (en) 2004-05-03 2012-10-02 Dexcom, Inc. Implantable analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US7640048B2 (en) 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US20060020192A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060121547A1 (en) * 2004-12-03 2006-06-08 Mcintire Mark Diffusion layer for an enzyme-based sensor application
US8097725B2 (en) * 2004-12-03 2012-01-17 Roche Diagnostics Operations, Inc. Luminescent indicator dye and optical sensor
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US20070081626A1 (en) * 2005-02-14 2007-04-12 Peter Rule Method and apparatus for enhancing accuracy of an analyte detection system
WO2006110193A2 (en) 2005-04-08 2006-10-19 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor
US8744546B2 (en) 2005-05-05 2014-06-03 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
EP1991110B1 (en) 2006-03-09 2018-11-07 DexCom, Inc. Systems and methods for processing analyte sensor data
WO2007120381A2 (en) 2006-04-14 2007-10-25 Dexcom, Inc. Analyte sensor
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
EP2152350A4 (en) 2007-06-08 2013-03-27 Dexcom Inc Integrated medicament delivery device for use with continuous analyte sensor
AT505337B1 (en) * 2007-06-14 2009-08-15 Joanneum Res Forschungsgesells SENSOR FOR THE DETECTION OF GASES
WO2009051901A2 (en) * 2007-08-30 2009-04-23 Pepex Biomedical, Llc Electrochemical sensor and method for manufacturing
US8702932B2 (en) 2007-08-30 2014-04-22 Pepex Biomedical, Inc. Electrochemical sensor and method for manufacturing
EP4098177A1 (en) 2007-10-09 2022-12-07 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US9839395B2 (en) 2007-12-17 2017-12-12 Dexcom, Inc. Systems and methods for processing sensor data
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US9445755B2 (en) 2008-11-14 2016-09-20 Pepex Biomedical, Llc Electrochemical sensor module
US8951377B2 (en) 2008-11-14 2015-02-10 Pepex Biomedical, Inc. Manufacturing electrochemical sensor module
WO2010056876A2 (en) 2008-11-14 2010-05-20 Pepex Biomedical, Llc Manufacturing electrochemical sensor module
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
EP2410910A4 (en) 2009-03-27 2014-10-15 Dexcom Inc Methods and systems for promoting glucose management
US9378443B2 (en) * 2009-05-14 2016-06-28 Ascensia Diabetes Care Holding Ag Calibration coded sensors and apparatus, systems and methods for reading same
GB2470757B (en) * 2009-06-04 2013-11-06 Haemaflow Ltd Non invasive gas analysis
US9949672B2 (en) 2009-12-17 2018-04-24 Ascensia Diabetes Care Holdings Ag Apparatus, systems and methods for determining and displaying pre-event and post-event analyte concentration levels
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9632055B2 (en) 2010-11-12 2017-04-25 Ascensia Diabetes Care Holdings Ag Auto-coded analyte sensors and apparatus, systems, and methods for detecting same
WO2012142502A2 (en) 2011-04-15 2012-10-18 Dexcom Inc. Advanced analyte sensor calibration and error detection
WO2012162151A2 (en) 2011-05-20 2012-11-29 Pepex Biomedical, Inc. Manufacturing electrochemical sensor modules
KR20140082642A (en) 2011-07-26 2014-07-02 글리젠스 인코포레이티드 Tissue implantable sensor with hermetically sealed housing
US10561353B2 (en) 2016-06-01 2020-02-18 Glysens Incorporated Biocompatible implantable sensor apparatus and methods
US10660550B2 (en) 2015-12-29 2020-05-26 Glysens Incorporated Implantable sensor apparatus and methods
US11224367B2 (en) 2012-12-03 2022-01-18 Pepex Biomedical, Inc. Sensor module and method of using a sensor module
CN107003264B (en) 2014-06-04 2020-02-21 普佩克斯生物医药有限公司 Electrochemical sensor and method of manufacturing an electrochemical sensor using advanced printing techniques
US20190000361A1 (en) * 2015-12-09 2019-01-03 The Texas A&M University System Implantable biosensors
US10638962B2 (en) 2016-06-29 2020-05-05 Glysens Incorporated Bio-adaptable implantable sensor apparatus and methods
US10638979B2 (en) 2017-07-10 2020-05-05 Glysens Incorporated Analyte sensor data evaluation and error reduction apparatus and methods
US11382540B2 (en) 2017-10-24 2022-07-12 Dexcom, Inc. Pre-connected analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11278668B2 (en) 2017-12-22 2022-03-22 Glysens Incorporated Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods
US11255839B2 (en) 2018-01-04 2022-02-22 Glysens Incorporated Apparatus and methods for analyte sensor mismatch correction
CN111707780A (en) * 2020-07-03 2020-09-25 安徽盛世新能源材料科技有限公司 Chemical detection method for content of antimony trioxide

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680268A (en) * 1985-09-18 1987-07-14 Children's Hospital Medical Center Implantable gas-containing biosensor and method for measuring an analyte such as glucose
US4689309A (en) * 1985-09-30 1987-08-25 Miles Laboratories, Inc. Test device, method of manufacturing same and method of determining a component in a sample
US4752115A (en) * 1985-02-07 1988-06-21 Spectramed, Inc. Optical sensor for monitoring the partial pressure of oxygen
US4810655A (en) * 1985-07-03 1989-03-07 Abbott Laboratories Method for measuring oxygen concentration
EP0409032A2 (en) * 1989-07-19 1991-01-23 Gesellschaft für Biotechnologische Forschung mbH (GBF) Optical biosensor
US5030420A (en) * 1982-12-23 1991-07-09 University Of Virginia Alumni Patents Foundation Apparatus for oxygen determination
US5208147A (en) * 1988-07-21 1993-05-04 Radiometer A/S Means for measuring a characteristic in a sample fluid
DE4323277A1 (en) * 1992-07-15 1994-01-20 Seiko Instr Inc Appts. for quantitative analysis of dissolved substances - is by chemical developed luminescence of immobilised enzyme treated body fluid, used e.g. for determn. of glucose or lactic acid levels in blood serum samples
US5352348A (en) * 1987-04-09 1994-10-04 Nova Biomedical Corporation Method of using enzyme electrode
WO1995008107A1 (en) * 1993-09-13 1995-03-23 Optical Sensors Incorporated A ratiometric fluorescence method to measure oxygen
EP0693271A1 (en) * 1994-07-18 1996-01-24 Minimed Inc. Optical glucose sensor
US5520883A (en) * 1987-11-13 1996-05-28 Miles Inc. Test devices for determination of glucose
WO1998015645A1 (en) * 1996-10-08 1998-04-16 Photonics Biosystems Microbiological assessment method and device utilizing oxygen gradient sensing

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT557307A (en) * 1955-02-23 1900-01-01
US3992158A (en) * 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
DE2508637C3 (en) * 1975-02-28 1979-11-22 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Arrangement for the optical measurement of blood gases
US4042335A (en) * 1975-07-23 1977-08-16 Eastman Kodak Company Integral element for analysis of liquids
JPS568549A (en) * 1979-07-02 1981-01-28 Fuji Photo Film Co Ltd Multilayer chemical analyzing material
US4734375A (en) * 1980-05-27 1988-03-29 Miles Laboratories, Inc. Ion specific test method
US4476870A (en) * 1982-03-30 1984-10-16 The United States Of America As Represented By The Department Of Health And Human Services Fiber optic PO.sbsb.2 probe
EP0105870B1 (en) * 1982-10-06 1987-02-11 Avl Ag Measurement device for determining the carbon dioxide content of a sample
AT379688B (en) * 1982-11-22 1986-02-10 List Hans SENSOR ELEMENT FOR DETERMINING THE O2 CONTENT OF A SAMPLE
JPS59171864A (en) * 1983-03-18 1984-09-28 Fuji Photo Film Co Ltd Multi-layered analytical element for quantitative analysis of bilirubin
US4649123A (en) * 1983-05-12 1987-03-10 Miles Laboratories, Inc. Ion test means having a hydrophilic carrier matrix
CA1222438A (en) * 1983-05-12 1987-06-02 Steven C. Charlton Unified test means for ion determination
JPS60108753A (en) * 1983-11-18 1985-06-14 Fuji Photo Film Co Ltd Multilayer chemical analysis element
US4670218A (en) * 1984-02-24 1987-06-02 Miles Laboratories, Inc. Ion test means having a porous carrier matrix
JPS61245057A (en) * 1985-04-23 1986-10-31 Fuji Photo Film Co Ltd Integral type multi-layered analyzing element
EP0227815A4 (en) * 1985-07-03 1988-06-23 Internat Biomedics Inc Methods of measuring oxygen concentration.
US5043286A (en) * 1985-07-03 1991-08-27 Abbott Laboratories Method and sensor for measuring oxygen concentration
US4919891A (en) * 1986-04-18 1990-04-24 Minnesota Mining And Manufacturing Company Sensor with overcoating and process for making same
US4824789B1 (en) * 1986-10-10 1996-08-13 Minnesota Mining & Mfg Gas sensor
US4895156A (en) * 1986-07-02 1990-01-23 Schulze John E Sensor system using fluorometric decay measurements
US4861727A (en) * 1986-09-08 1989-08-29 C. R. Bard, Inc. Luminescent oxygen sensor based on a lanthanide complex
US5190729A (en) * 1986-09-08 1993-03-02 C. R. Bard, Inc. Luminescent oxygen sensor based on a lanthanide complex
US5075127A (en) * 1986-10-10 1991-12-24 Minnesota Mining And Manufacturing Company Sensor with overcoating and process for making same
US4808539A (en) * 1987-04-15 1989-02-28 Technicon Instruments Corporation Compounds, reagents and procedures for determining cations
IL84422A (en) * 1987-04-15 1993-03-15 Technicon Instr Process for the preparation of chromogenic cryptahemispherands
US4716363A (en) * 1987-05-08 1987-12-29 Hewlett-Packard Company Exponential decay time constant measurement using frequency of offset phase-locked loop: system and method
AT389590B (en) * 1987-05-27 1989-12-27 Avl Verbrennungskraft Messtech METHOD FOR THE CONTINUOUS, QUANTITATIVE DETERMINATION OF SULFUR DIOXIDE AND ARRANGEMENT FOR IMPLEMENTING THE METHOD
AT388248B (en) * 1987-07-20 1989-05-26 Avl Verbrennungskraft Messtech COVER LAYER, PREFERABLY FOR SAMPLE-SIDE ATTACHMENT TO OPTICAL ION SENSORS
US4974929A (en) * 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
DK163194C (en) * 1988-12-22 1992-06-22 Radiometer As METHOD OF PHOTOMETRIC IN VITRO DETERMINING A BLOOD GAS PARAMETER IN A BLOOD TEST
US5173432A (en) * 1987-12-14 1992-12-22 The Dow Chemical Company Apparatus and method for measuring the concentration or partial pressure of oxygen
US5047350A (en) * 1989-01-19 1991-09-10 Eastman Kodak Company Material and method for oxygen sensing
DE3923950A1 (en) * 1989-07-19 1991-01-31 Biotechnolog Forschung Gmbh FIBER OPTICAL SENSOR ARRANGEMENT FOR DETERMINING AN ANALYTIC, IN PARTICULAR OF GLUCOSE
US5127405A (en) * 1990-02-16 1992-07-07 The Boc Group, Inc. Biomedical fiber optic probe with frequency domain signal processing
US5081042A (en) * 1990-03-20 1992-01-14 Minnesota Mining And Manufacturing Company Ionic component sensor and method for making and using same
US5081041A (en) * 1990-04-03 1992-01-14 Minnesota Mining And Manufacturing Company Ionic component sensor and method for making and using same
EP0694164A1 (en) * 1991-05-03 1996-01-31 Joseph R. Lakowicz Method for optically measuring chemical analytes
US5281825A (en) * 1991-09-05 1994-01-25 The University Of Maryland School Of Medicine Phase fluorometry using a modulated electroluminescent lamp as a light source
US6362175B1 (en) * 1991-09-20 2002-03-26 The Trustees Of The University Of Pennsylvania Porphyrin compounds for imaging tissue oxygen
US5453248A (en) * 1992-03-09 1995-09-26 Optical Sensors Incorporated Cross-linked gas permeable membrane of a cured perfluorinated urethane polymer, and optical gas sensors fabricated therewith
US5298144A (en) * 1992-09-15 1994-03-29 The Yellow Springs Instrument Company, Inc. Chemically wired fructose dehydrogenase electrodes
US5326531A (en) * 1992-12-11 1994-07-05 Puritan-Bennett Corporation CO2 sensor using a hydrophilic polyurethane matrix and process for manufacturing
US5341805A (en) * 1993-04-06 1994-08-30 Cedars-Sinai Medical Center Glucose fluorescence monitor and method
US5387329A (en) * 1993-04-09 1995-02-07 Ciba Corning Diagnostics Corp. Extended use planar sensors
US5387525A (en) * 1993-09-03 1995-02-07 Ciba Corning Diagnostics Corp. Method for activation of polyanionic fluorescent dyes in low dielectric media with quaternary onium compounds
US5462879A (en) * 1993-10-14 1995-10-31 Minnesota Mining And Manufacturing Company Method of sensing with emission quenching sensors
US5462858A (en) * 1993-12-29 1995-10-31 Eastman Kodak Company Dry multilayer analytical elements for assaying transaminases
DE69503897T2 (en) * 1994-03-25 1999-01-14 Novartis Ag OPTICAL SENSOR FOR DETERMINING IONS
ATE176048T1 (en) * 1994-05-02 1999-02-15 Novartis Ag OPTICAL SENSOR SYSTEM FOR DETERMINING PH VALUES AND IONIC STRENGTH
US5494562A (en) * 1994-06-27 1996-02-27 Ciba Corning Diagnostics Corp. Electrochemical sensors
US5464777A (en) * 1994-09-26 1995-11-07 Miles Inc. Dry reagent for creatinine assay
US5863460A (en) * 1996-04-01 1999-01-26 Chiron Diagnostics Corporation Oxygen sensing membranes and methods of making same

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030420A (en) * 1982-12-23 1991-07-09 University Of Virginia Alumni Patents Foundation Apparatus for oxygen determination
US4752115A (en) * 1985-02-07 1988-06-21 Spectramed, Inc. Optical sensor for monitoring the partial pressure of oxygen
US4810655A (en) * 1985-07-03 1989-03-07 Abbott Laboratories Method for measuring oxygen concentration
US4680268A (en) * 1985-09-18 1987-07-14 Children's Hospital Medical Center Implantable gas-containing biosensor and method for measuring an analyte such as glucose
US4689309A (en) * 1985-09-30 1987-08-25 Miles Laboratories, Inc. Test device, method of manufacturing same and method of determining a component in a sample
US5352348A (en) * 1987-04-09 1994-10-04 Nova Biomedical Corporation Method of using enzyme electrode
US5520883A (en) * 1987-11-13 1996-05-28 Miles Inc. Test devices for determination of glucose
US5208147A (en) * 1988-07-21 1993-05-04 Radiometer A/S Means for measuring a characteristic in a sample fluid
EP0409032A2 (en) * 1989-07-19 1991-01-23 Gesellschaft für Biotechnologische Forschung mbH (GBF) Optical biosensor
DE4323277A1 (en) * 1992-07-15 1994-01-20 Seiko Instr Inc Appts. for quantitative analysis of dissolved substances - is by chemical developed luminescence of immobilised enzyme treated body fluid, used e.g. for determn. of glucose or lactic acid levels in blood serum samples
WO1995008107A1 (en) * 1993-09-13 1995-03-23 Optical Sensors Incorporated A ratiometric fluorescence method to measure oxygen
EP0693271A1 (en) * 1994-07-18 1996-01-24 Minimed Inc. Optical glucose sensor
WO1998015645A1 (en) * 1996-10-08 1998-04-16 Photonics Biosystems Microbiological assessment method and device utilizing oxygen gradient sensing

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7222024B2 (en) 2002-12-31 2007-05-22 Kuo-Jeng Wang Method for determining the concentration of blood glucose
DE10319295B4 (en) * 2002-12-31 2008-04-03 Transpacific Ip, Ltd. Method for determining the concentration of glucose in the blood
US8478536B2 (en) 2002-12-31 2013-07-02 Transpacific Systems, Llc Method for determining the concentration of blood glucose
US6872573B2 (en) 2003-01-02 2005-03-29 Bayer Corporation Fluorescent creatinine assay
US8320986B2 (en) 2003-04-04 2012-11-27 Transpacific Systems, Llc Method for determining the resolution of blood glucose
CN103091264A (en) * 2011-10-31 2013-05-08 爱科来株式会社 Analytical instrument and analytical method
EP2592153A3 (en) * 2011-10-31 2013-06-12 ARKRAY, Inc. Analytical instrument and analytical method
US8993313B2 (en) 2011-10-31 2015-03-31 Arkray, Inc. Analytical instrument and analytical method
US10947577B2 (en) 2012-02-16 2021-03-16 3M Innovative Properties Company Biological sterilization indicator devices and methods of use

Also Published As

Publication number Publication date
JP2002523733A (en) 2002-07-30
US6107083A (en) 2000-08-22
EP1112374A1 (en) 2001-07-04
CA2340983A1 (en) 2000-03-02
AU5188399A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
US6107083A (en) Optical oxidative enzyme-based sensors
Moreno-Bondi et al. Oxygen optrode for use in a fiber-optic glucose biosensor
Preininger et al. Optical fiber sensor for biological oxygen demand
Tsai et al. Simultaneous determination of pH, urea, acetylcholine and heavy metals using array-based enzymatic optical biosensor
Wolfbeis et al. A new sensing material for optical oxygen measurement, with the indicator embedded in an aqueous phase
US20060121547A1 (en) Diffusion layer for an enzyme-based sensor application
Wolfbeis et al. Reversible optical sensor membrane for hydrogen peroxide using an immobilized fluorescent probe, and its application to a glucose biosensor
CN100439513C (en) Method and reagent system having a non-regenerative enzyme-coenzyme complex
EP1000171B1 (en) Fluorescent polymeric sensor for the detection of urea
Papkovsky Luminescent porphyrins as probes for optical (bio) sensors
Tian et al. Dually fluorescent sensing of pH and dissolved oxygen using a membrane made from polymerizable sensing monomers
US20010012539A1 (en) Methods for producing optical sensors with reflective materials
Abel et al. Fast responsive, optical trace level ammonia sensor for environmental monitoring
JP2001512236A (en) Method and apparatus for normalizing fluorescence intensity signal
US5958786A (en) Fluorescent polymeric sensor for the detection of creatinine
Neubauer et al. Fibre-optic glucose biosensor using enzyme membranes with 2-D crystalline structure
US20040171094A1 (en) Oxygen sensors disposed on a microtiter plate
JP2004517321A (en) Sensor for optical emission measurement of analytes
Posch et al. Optical sensor for hydrogen peroxide
EP1496126B1 (en) Nanoparticles for optical sensors
Guo et al. A novel sensor based on the porous plastic probe for determination of dissolved oxygen in seawater
de Marcos et al. Characterization of a urea optical sensor based on polypyrrole
EP0916091B1 (en) Light-sensitive compositions for oxygen optrodes
Huber et al. Serum chloride optical sensors based on dynamic quenching of the fluorescence of photo-immobilized lucigenin
US7427491B2 (en) Nanoparticles for optical sensors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999936915

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2340983

Country of ref document: CA

Ref country code: CA

Ref document number: 2340983

Kind code of ref document: A

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1999936915

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999936915

Country of ref document: EP